483 Xiamen LP Pharmaceutical Nov 2018

483 Xiamen LP Pharmaceutical Nov 2018

Jonathan Chapman FDA$119.00 - Available Now

FDA investigators audited the Xiamen LP Pharmaceutical - Xiamen, China facility and issued inspectional observations (via FDA 483) on 16 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Nov 2018
  • Location: Xiamen, China
  • FEI: 3013002864
Add To Cart